Imaging with [89Zr]Panitumumab-PET/MRI in Patients with Newly Diagnosed Colorectal Cancer

NCT03764137 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study was not able to enroll any subjects

Conditions

Metastatic Colon Cancer

Interventions

DRUG: [89Zr]Panitumumab PET-MRI

Sponsor

University of Alabama at Birmingham